Titre : Contamination radioactive des aliments

Contamination radioactive des aliments : Questions médicales fréquentes

Termes MeSH sélectionnés :

Cell Line Authentication
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Contamination radioactive des aliments : Questions médicales les plus fréquentes", "headline": "Contamination radioactive des aliments : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Contamination radioactive des aliments : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-01-03", "dateModified": "2025-03-28", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Contamination radioactive des aliments" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Hygiène radiologique", "url": "https://questionsmedicales.fr/mesh/D011870", "about": { "@type": "MedicalCondition", "name": "Hygiène radiologique", "code": { "@type": "MedicalCode", "code": "D011870", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N06.850.810" } } }, "about": { "@type": "MedicalCondition", "name": "Contamination radioactive des aliments", "alternateName": "Food Contamination, Radioactive", "code": { "@type": "MedicalCode", "code": "D005507", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "I Ye Kolpakov", "url": "https://questionsmedicales.fr/author/I%20Ye%20Kolpakov", "affiliation": { "@type": "Organization", "name": "State Institution «National Research Center for Radiation Medicine of the National Academy of Medical Sciences of Ukraine», 53 Yuriia Illienka St., Kyiv, 04050, Ukraine." } }, { "@type": "Person", "name": "V Yu Vdovenko", "url": "https://questionsmedicales.fr/author/V%20Yu%20Vdovenko", "affiliation": { "@type": "Organization", "name": "State Institution «National Research Center for Radiation Medicine of the National Academy of Medical Sciences of Ukraine», 53 Yuriia Illienka St., Kyiv, 04050, Ukraine." } }, { "@type": "Person", "name": "Ryszard Misiak", "url": "https://questionsmedicales.fr/author/Ryszard%20Misiak", "affiliation": { "@type": "Organization", "name": "Institute of Nuclear Physics, Polish Academy of Sciences, Radzikowskiego 152, 31-342 Kraków, Poland." } }, { "@type": "Person", "name": "Yuki Sato", "url": "https://questionsmedicales.fr/author/Yuki%20Sato", "affiliation": { "@type": "Organization", "name": "Collaborative Laboratories for Advanced Decommissioning Science, Japan Atomic Energy Agency, 790-1 Motooka aza Ohtsuka, Tomioka-machi, Futaba-gun, Fukushima, Japan. Electronic address: sato.yuki@jaea.go.jp." } }, { "@type": "Person", "name": "Vladimir Drozdovitch", "url": "https://questionsmedicales.fr/author/Vladimir%20Drozdovitch", "affiliation": { "@type": "Organization", "name": "Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, 9609 Medical Center Drive, Room 7E548 MSC 9778, Bethesda, MD, 20892-9778, USA. drozdovv@mail.nih.gov." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Spatially resolved measurement of helium atom emission line spectrum in scrape-off layer of Heliotron J by near-infrared Stokes spectropolarimetry.", "datePublished": "2022-09-23", "url": "https://questionsmedicales.fr/article/36151115", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41598-022-19747-8" } }, { "@type": "ScholarlyArticle", "name": "Outcomes of Second-Line Intravitreal Anti-VEGF Switch Therapy in Radiation Retinopathy Secondary to Uveal Melanoma: Moving from Bevacizumab to Aflibercept.", "datePublished": "2022-09-01", "url": "https://questionsmedicales.fr/article/36925730", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1159/000526548" } }, { "@type": "ScholarlyArticle", "name": "Analysis of A Disintegrin and Metalloprotease 17 (ADAM17) Expression as a Prognostic Marker in Ovarian Cancer Patients Undergoing First-Line Treatment Plus Bevacizumab.", "datePublished": "2022-08-31", "url": "https://questionsmedicales.fr/article/36140519", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/diagnostics12092118" } }, { "@type": "ScholarlyArticle", "name": "A mental health survey among young front-line clinicians in high-risk areas during the COVID-19 sporadic epidemic in China.", "datePublished": "2022-08-30", "url": "https://questionsmedicales.fr/article/36111303", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fpsyt.2022.872331" } }, { "@type": "ScholarlyArticle", "name": "Real-World Outcomes of Ribociclib and Aromatase Inhibitor Use in First Line Hormone Receptor Positive, HER2-Negative Metastatic Breast Cancer.", "datePublished": "2022-08-30", "url": "https://questionsmedicales.fr/article/36151018", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.clbc.2022.08.011" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Environnement et santé publique", "item": "https://questionsmedicales.fr/mesh/D004778" }, { "@type": "ListItem", "position": 3, "name": "Santé publique", "item": "https://questionsmedicales.fr/mesh/D011634" }, { "@type": "ListItem", "position": 4, "name": "Hygiène radiologique", "item": "https://questionsmedicales.fr/mesh/D011870" }, { "@type": "ListItem", "position": 5, "name": "Contamination radioactive des aliments", "item": "https://questionsmedicales.fr/mesh/D005507" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Contamination radioactive des aliments - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Contamination radioactive des aliments", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-11", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Contamination radioactive des aliments", "description": "Comment détecte-t-on la contamination radioactive des aliments ?\nQuels sont les indicateurs de contamination radioactive ?\nLes inspections alimentaires incluent-elles la radioactivité ?\nQuels appareils mesurent la radioactivité dans les aliments ?\nPeut-on détecter la radioactivité par des méthodes visuelles ?", "url": "https://questionsmedicales.fr/mesh/D005507?mesh_terms=Cell+Line+Authentication&page=999#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Contamination radioactive des aliments", "description": "Quels symptômes indiquent une exposition à des aliments radioactifs ?\nLa contamination radioactive cause-t-elle des maladies ?\nLes symptômes apparaissent-ils immédiatement après ingestion ?\nY a-t-il des symptômes spécifiques pour les enfants ?\nComment la radioactivité affecte-t-elle le système immunitaire ?", "url": "https://questionsmedicales.fr/mesh/D005507?mesh_terms=Cell+Line+Authentication&page=999#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Contamination radioactive des aliments", "description": "Comment prévenir la contamination radioactive des aliments ?\nLes contrôles de sécurité alimentaire sont-ils efficaces ?\nQuelles sont les recommandations pour les agriculteurs ?\nLes consommateurs peuvent-ils réduire les risques ?\nLes étiquettes alimentaires indiquent-elles la radioactivité ?", "url": "https://questionsmedicales.fr/mesh/D005507?mesh_terms=Cell+Line+Authentication&page=999#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Contamination radioactive des aliments", "description": "Quel traitement existe pour la contamination radioactive ?\nLes soins d'urgence sont-ils nécessaires en cas d'exposition ?\nPeut-on utiliser des médicaments pour réduire les effets ?\nLa décontamination des aliments est-elle possible ?\nQuels sont les soins post-exposition recommandés ?", "url": "https://questionsmedicales.fr/mesh/D005507?mesh_terms=Cell+Line+Authentication&page=999#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Contamination radioactive des aliments", "description": "Quelles complications peuvent survenir après exposition ?\nLa contamination radioactive affecte-t-elle la reproduction ?\nLes effets de la radioactivité sont-ils réversibles ?\nY a-t-il des risques pour les générations futures ?\nComment la radioactivité affecte-t-elle la santé mentale ?", "url": "https://questionsmedicales.fr/mesh/D005507?mesh_terms=Cell+Line+Authentication&page=999#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Contamination radioactive des aliments", "description": "Quels sont les principaux facteurs de risque de contamination ?\nLes aliments importés présentent-ils un risque ?\nLes conditions climatiques influencent-elles la contamination ?\nLes populations vulnérables sont-elles plus à risque ?\nL'alimentation biologique est-elle plus sûre ?", "url": "https://questionsmedicales.fr/mesh/D005507?mesh_terms=Cell+Line+Authentication&page=999#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment détecte-t-on la contamination radioactive des aliments ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Des tests de radiométrie et des analyses de laboratoire sont utilisés pour détecter la radioactivité." } }, { "@type": "Question", "name": "Quels sont les indicateurs de contamination radioactive ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les niveaux de radiation mesurés en becquerels par kilogramme d'aliment sont des indicateurs clés." } }, { "@type": "Question", "name": "Les inspections alimentaires incluent-elles la radioactivité ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les inspections peuvent inclure des tests pour la radioactivité dans les aliments." } }, { "@type": "Question", "name": "Quels appareils mesurent la radioactivité dans les aliments ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des détecteurs de radiation et des spectromètres gamma sont couramment utilisés." } }, { "@type": "Question", "name": "Peut-on détecter la radioactivité par des méthodes visuelles ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Non, la radioactivité ne peut pas être détectée visuellement; des instruments spécifiques sont nécessaires." } }, { "@type": "Question", "name": "Quels symptômes indiquent une exposition à des aliments radioactifs ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes peuvent inclure nausées, vomissements, fatigue et troubles gastro-intestinaux." } }, { "@type": "Question", "name": "La contamination radioactive cause-t-elle des maladies ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une exposition prolongée peut entraîner des maladies graves, y compris des cancers." } }, { "@type": "Question", "name": "Les symptômes apparaissent-ils immédiatement après ingestion ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Pas toujours; certains effets peuvent prendre des jours ou des mois à se manifester." } }, { "@type": "Question", "name": "Y a-t-il des symptômes spécifiques pour les enfants ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Les enfants peuvent être plus sensibles et présenter des symptômes plus graves que les adultes." } }, { "@type": "Question", "name": "Comment la radioactivité affecte-t-elle le système immunitaire ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Elle peut affaiblir le système immunitaire, rendant l'individu plus vulnérable aux infections." } }, { "@type": "Question", "name": "Comment prévenir la contamination radioactive des aliments ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Éviter les zones contaminées et suivre les recommandations des autorités sanitaires." } }, { "@type": "Question", "name": "Les contrôles de sécurité alimentaire sont-ils efficaces ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des contrôles réguliers aident à détecter et prévenir la contamination radioactive." } }, { "@type": "Question", "name": "Quelles sont les recommandations pour les agriculteurs ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Éviter l'utilisation d'eau contaminée et surveiller les niveaux de radiation dans le sol." } }, { "@type": "Question", "name": "Les consommateurs peuvent-ils réduire les risques ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, en choisissant des aliments provenant de sources sûres et en suivant les alertes sanitaires." } }, { "@type": "Question", "name": "Les étiquettes alimentaires indiquent-elles la radioactivité ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Non, la radioactivité n'est généralement pas indiquée sur les étiquettes alimentaires." } }, { "@type": "Question", "name": "Quel traitement existe pour la contamination radioactive ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement peut inclure des agents chélateurs pour éliminer les radionucléides du corps." } }, { "@type": "Question", "name": "Les soins d'urgence sont-ils nécessaires en cas d'exposition ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des soins d'urgence peuvent être nécessaires pour traiter les symptômes aigus." } }, { "@type": "Question", "name": "Peut-on utiliser des médicaments pour réduire les effets ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Des médicaments peuvent aider à atténuer certains effets, mais ne neutralisent pas la radioactivité." } }, { "@type": "Question", "name": "La décontamination des aliments est-elle possible ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Non, une fois contaminés, les aliments radioactifs ne peuvent pas être décontaminés efficacement." } }, { "@type": "Question", "name": "Quels sont les soins post-exposition recommandés ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Surveillance médicale et tests réguliers pour détecter d'éventuels effets à long terme." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir après exposition ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications incluent des cancers, des maladies thyroïdiennes et des troubles immunitaires." } }, { "@type": "Question", "name": "La contamination radioactive affecte-t-elle la reproduction ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut entraîner des problèmes de fertilité et des malformations congénitales." } }, { "@type": "Question", "name": "Les effets de la radioactivité sont-ils réversibles ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Certains effets peuvent être réversibles, mais d'autres, comme le cancer, peuvent ne pas l'être." } }, { "@type": "Question", "name": "Y a-t-il des risques pour les générations futures ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la contamination peut avoir des effets héréditaires sur les générations futures." } }, { "@type": "Question", "name": "Comment la radioactivité affecte-t-elle la santé mentale ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Elle peut causer de l'anxiété, du stress et des troubles psychologiques chez les exposés." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque de contamination ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les zones proches de centrales nucléaires et les sites d'accidents nucléaires sont à risque." } }, { "@type": "Question", "name": "Les aliments importés présentent-ils un risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains aliments importés peuvent être contaminés, surtout en provenance de zones à risque." } }, { "@type": "Question", "name": "Les conditions climatiques influencent-elles la contamination ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des événements comme les pluies acides peuvent augmenter la contamination des sols et des cultures." } }, { "@type": "Question", "name": "Les populations vulnérables sont-elles plus à risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les enfants, les femmes enceintes et les personnes immunodéprimées sont plus vulnérables." } }, { "@type": "Question", "name": "L'alimentation biologique est-elle plus sûre ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Pas nécessairement; la contamination peut affecter tous les types d'aliments, y compris biologiques." } } ] } ] }

Sources (10000 au total)

Outcomes of Second-Line Intravitreal Anti-VEGF Switch Therapy in Radiation Retinopathy Secondary to Uveal Melanoma: Moving from Bevacizumab to Aflibercept.

Radiation retinopathy is a dose-dependent complication of the retina following exposure to ionizing radiation. The objective of this prospective case series is to determine the clinical efficacy of in... A case series of 30 patients with a mean age of 57 ± 15 years with radiation retinopathy were enrolled. Visual acuity (VA) and central foveal thickness (CFT) responses to therapy were assessed with re... Regression analyses showed a statistically significant reduction in CFT and improvements in VA following the switch to treatment by aflibercept at 1 month, 3 months, and 6 months. The mean CFT improve... This pilot study suggests that patients with radiation retinopathy who have failed monthly intravitreal bevacizumab may respond to aflibercept....

A mental health survey among young front-line clinicians in high-risk areas during the COVID-19 sporadic epidemic in China.

The sporadic coronavirus disease (COVID-19) epidemic has placed enormous psychological stress on people, especially clinicians. The objective of this study was to examine depression, anxiety, quality ... In this cross-sectional study, demographic information, COVID-19-related questions, anxiety (Generalized Anxiety Disorder-7, GAD-7), depression (Patient Health Questionnaire-9, PHQ-9), insomnia (Insom... A total of 146 young front-line clinicians were included. The prevalence rates of depression, anxiety, and anxiety-depression comorbidity were 37.7% (95% CI = 29.7-45.6%), 26.0% (95% CI = 18.8-33.2%),... The prevalence of depression, anxiety, and even anxiety-depression comorbidity was high among young front-line clinicians in high-risk areas during the COVID-19 sporadic epidemic in China. Various bio...

Real-World Outcomes of Ribociclib and Aromatase Inhibitor Use in First Line Hormone Receptor Positive, HER2-Negative Metastatic Breast Cancer.

International guidelines recommend combining a CDK4/6 inhibitor and endocrine therapy (ET) as first line treatment for hormone receptor (HR) positive, HER2 negative metastatic breast cancer (MBC). Res... KARMA is a non-interventional registry of Australian patients receiving first-line treatment with ribociclib and aromatase inhibitor (AI), obtained via a Medicine Access Program (MAP) for HR+, HER2- M... Data from 160 patients at 17 sites was analysed. Median follow-up is 36.5 months. Compared to MONALEESA-2, patients were numerically younger (54.3 vs. 62 years), with higher rates of bone-only metasta... The ribociclib and AI combination was well tolerated in this real-world setting. The KARMA registry cohort achieved a superior PFS (>36.5 months) to MONALEESA-2, potentially due to more favourable bas...

A real-world analysis of nanoliposomal-irinotecan with 5-fluorouracil and folinic acid as third- or later-line therapy in patients with metastatic pancreatic adenocarcinoma.

Nanoliposomal encapsulation of irinotecan (nal-IRI) with 5-fluorouracil and leucovorin (5-FU/LV) has shown a survival benefit for gemcitabine-pretreated patients with metastatic pancreatic adenocarcin... This multicenter, retrospective, non-comparative observational study included mPAC patients who received nal-IRI plus 5-FU/LV as third- or later-line therapy after disease progression on first-line FO... In all, 128 patients who received nal-IRI plus 5-FU/LV beyond second-line treatment between October 2017 and July 2021 were analyzed. Most patients (82%) received nal-IRI plus 5-FU/LV as a third-line ... Our real-world data indicated that nal-IRI plus 5-FU/LV can be effective not only as second-line therapy, but also as third-line or later-line treatment in selected patients. Nal-IRI plus 5-FU/LV may ...

Use of First-Line Immune Checkpoint Inhibitors and Association With Overall Survival Among Patients With Metastatic Melanoma in the Anti-PD-1 Era.

In 2015, first-line programmed cell death 1 (PD-1) immune checkpoint inhibitors (ICI) were Food and Drug Administration (FDA)-approved and National Comprehensive Cancer Network (NCCN)-recommended for ... To determine the rates of ICI use for metastatic melanoma following FDA approval in 2015 and characterize OS associated with first-line ICI use in this patient population.... In this retrospective, nationwide cohort study, adult patients (≥20 years of age) with newly diagnosed stage IV cutaneous melanoma from 2010 to 2019 were identified using the US National Cancer Databa... Patients were compared based on first-line ICI receipt vs not.... The OS and use of first-line ICI in 2016 to 2019 were assessed using multivariable Cox and logistic regression, respectively. To account for immortal time bias in receiving ICI, landmark time points w... Among 16 831 patients with stage IV melanoma, 11 435 (67.9%) of patients were male; 116 (0.69%) were Asian or Pacific Islander, 475 (2.82%) were Hispanic, 270 (1.60%) were non-Hispanic Black, 15 711 (... Following anti-PD-1 approval in 2015, first-line ICI was associated with substantial OS improvements for patients with stage IV melanoma, including those with brain metastases. As of 2019, 38% of pati...